Patents by Inventor Ioanna Stamati

Ioanna Stamati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233706
    Abstract: The invention provides compounds comprising a therapeutic agent coupled to a carrier molecule, with a minimum coupling ratio of 5:1; wherein the carrier molecule is (i) an antibody fragment or derivative thereof or (ii) an antibody mimetic or derivative thereof; and wherein the therapeutic agents are coupled onto a lysine amino acid residue; and further wherein the therapeutic agent is not a photosensitising agent. There is also provided uses, methods relating to such compounds, as well as processes for their manufacture.
    Type: Application
    Filed: November 19, 2021
    Publication date: July 28, 2022
    Inventors: Mahendra Persaud Deonarain, Gokhan Yahioglu, Ioanna Stamati, Savvas Saouros, Prashant Bhimrao Kapadnis
  • Patent number: 11202837
    Abstract: The invention provides compounds comprising a therapeutic agent coupled to a carrier molecule, with a minimum coupling ratio of 5:1; wherein the carrier molecule is (i) an antibody fragment or derivative thereof or (ii) an antibody mimetic or derivative thereof; and wherein the therapeutic agents are coupled onto a lysine amino acid residue; and further wherein the therapeutic agent is not a photosensitising agent. There is also provided uses, methods relating to such compounds, as well as processes for their manufacture.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: December 21, 2021
    Assignee: ANTIKOR BIOPHARMA LIMITED
    Inventors: Mahendra Persaud Deonarain, Gokhan Yahioglu, Ioanna Stamati, Savvas Saouros, Prashant Bhimrao Kapadnis
  • Publication number: 20170360951
    Abstract: The invention provides compounds comprising a therapeutic agent coupled to a carrier molecule, with a minimum coupling ratio of 5:1; wherein the carrier molecule is (i) an antibody fragment or derivative thereof or (ii) an antibody mimetic or derivative thereof; and wherein the therapeutic agents are coupled onto a lysine amino acid residue; and further wherein the therapeutic agent is not a photosensitising agent. There is also provided uses, methods relating to such compounds, as well as processes for their manufacture.
    Type: Application
    Filed: September 25, 2015
    Publication date: December 21, 2017
    Applicants: Antikor Biopharma Limited, Antikor Biopharma Limited
    Inventors: Mahendra Persaud Deonarain, Gokhan Yahioglu, Ioanna Stamati, Savvas Saouros, Prashant Bhimrao Kapadnis
  • Publication number: 20150133653
    Abstract: The invention provides compounds of Formula I: wherein b, D, R1, R2, G, Ra and Rb have meanings given in the description, or pharmaceutically-acceptable salts or solvates, or pharmaceutically functional derivatives thereof. The invention further provides process for conjugating the compounds to carrier molecules and uses of such compounds and conjugates in the treatment of disease.
    Type: Application
    Filed: November 20, 2014
    Publication date: May 14, 2015
    Inventors: Gokhan Yahioglu, Ioanna Stamati, Mahendra Deonarain
  • Publication number: 20120070377
    Abstract: The invention provides compounds of Formula (I): wherein b, D, R1, R2, G, Ra and Rb have meanings given in the description, or pharmaceutically-acceptable salts or solvates, or pharmaceutically functional derivatives thereof. The invention further provides process for conjugating the compounds to carrier molecules and uses of such compounds and conjugates in the treatment of disease.
    Type: Application
    Filed: March 19, 2010
    Publication date: March 22, 2012
    Inventors: Gokhan Yahioglu, Ioanna Stamati, Mahendra Deonarain